[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[e-drug] Paediatric drug formulations (cont'd)


  • From: "Beverley Snell" <bev@burnet.edu.au>
  • Date: Fri, 18 Feb 2005 09:02:44 +1100

E-DRUG: Paediatric drug formulations (cont'd)
---------------------------------------------

Dear Atieno

< However, what we need now is scientists like you to give us some
backing in terms of such studies. As a quick concern, why is it that
malaria deaths in children in Africa are not on the decline despite
the availability of medicines for prevention and treatment? Could
resistance to these medicines be emerging out of underdosing due to
the pill splitting practices? >

I wonder whether it is worth raising again the issue aired in the
Essential Drugs Monitor 33 by Hilbrand Haak in his review of the
study by Maponga and Ondari: The quality of antimalarials: A study
in selected African Countries. WHO/EDM/PAR/2003.4. The problem
with poor quality products was exposed leading to confusion about
whether resistance was responsible for treatment failure or whether
insufficient ingredients in the products were the cause.

Beverley

Beverley Snell
Centre for International Health
Macfarlane Burnet Institute for Medical Research & Public Health
GPO Box 2284, Melbourne 3001 Australia
http://www.burnet.internationalhealth.edu.au

Telephone 613 9282 2115 / 9282 2275
Fax 61 3 9282 2144 or 9282 2100
Time zone: 11 hours ahead of GMT.
email <bev@burnet.edu.au>

Site: Alfred Medical Research & Education Precinct (AMREP),
corner Punt & Commercial Roads, Prahran 3181